Inavolisib Patent Expiration

Inavolisib was first introduced by Genentech Inc in its drug Itovebi on Oct 10, 2024.

Inavolisib Patents

Given below is the list of patents protecting Inavolisib, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Itovebi	US11028100	Polymorphs and solid forms of (s)-2-((2-((s)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide, and methods of production	Apr 26, 2038	Genentech Inc
Itovebi	US10851091	Benzoxazepin oxazolidinone compounds and methods of use	Jul 01, 2036	Genentech Inc
Itovebi	US11760753	Benzoxazepin oxazolidinone compounds and methods of use	Jul 01, 2036	Genentech Inc
Itovebi	US9650393	Benzoxazepin oxazolidinone compounds and methods of use	Jul 01, 2036	Genentech Inc
Itovebi	US8242104	Benzoxazepin P13K inhibitor compounds and methods of use	Sep 27, 2030	Genentech Inc
Itovebi	US8343955	Benzoxazepin PI3K inhibitor compounds and methods of use	Sep 27, 2030	Genentech Inc

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List